Financials
Reported figures only · latest: Q4 2025
USD · US GAAP
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income13 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | $548.5M | $456.9M |
|---|
| FY24 | $630.2M | $37.7M |
|---|
| FY23 | $838M | $100.8M |
|---|
| FY22 | $426.4M | −$360.8M |
|---|
| FY21 | $356.1M | −$194.6M |
|---|
| FY20 | $228M | −$125.7M |
|---|
| FY19 | $204.9M | −$106M |
|---|
| FY18 | $214.1M | −$74.8M |
|---|
| FY17 | $241.2M | −$26.7M |
|---|
| FY16 | $216.1M | $11.7M |
|---|
| FY15 | $178.2M | - |
|---|
| FY14 | $87.3M | −$7.3M |
|---|
| FY13 | - | - |
|---|
MarginsShare of revenue- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|
| FY25 | 38.7% | −7.1% | 83.3% |
|---|
| FY24 | 44.6% | −6.9% | 6% |
|---|
| FY23 | 54.1% | 2.2% | 12% |
|---|
| FY22 | 27% | −95.6% | −84.6% |
|---|
| FY21 | - | −92.2% | −54.7% |
|---|
| FY20 | - | −86.3% | −55.2% |
|---|
| FY19 | - | −71.4% | −51.7% |
|---|
| FY18 | - | −43.3% | −34.9% |
|---|
| FY17 | 29.6% | −22.1% | −11.1% |
|---|
| FY16 | 31% | −21.6% | 5.4% |
|---|
| FY15 | 41.2% | −5.5% | - |
|---|
| FY14 | 38.8% | −20.9% | −8.4% |
|---|
| FY13 | - | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | −$78.8M |
|---|
| FY24 | −$17.4M |
|---|
| FY23 | $186.6M |
|---|
| FY22 | −$305.3M |
|---|
| FY21 | −$220.6M |
|---|
| FY20 | −$70M |
|---|
| FY19 | −$89.5M |
|---|
| FY18 | −$39.2M |
|---|
| FY17 | −$14M |
|---|
| FY16 | −$13.9M |
|---|
| FY15 | −$12.7M |
|---|
| FY14 | $4.6M |
|---|
| FY13 | - |
|---|
Returned to shareholdersDividends paid and shares bought backShow the numbers
| Year | Buybacks |
|---|
| FY25 | - |
|---|
| FY24 | $36.1M |
|---|
| FY23 | $9.1M |
|---|
| FY22 | $48.1M |
|---|
| FY21 | $27.3M |
|---|
| FY20 | $12.9M |
|---|
| FY19 | $346K |
|---|
| FY18 | $5.5M |
|---|
| FY17 | $1.4M |
|---|
| FY16 | $604K |
|---|
| FY15 | $1.8M |
|---|
| FY14 | - |
|---|
| FY13 | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SEC- HUTCHMED (China)
- Healthcare median
Show the numbers
| Year | HUTCHMED (China) | Healthcare median |
|---|
| FY25 | 83.3% | −30.6% |
|---|
| FY24 | 6% | −47% |
|---|
| FY23 | 12% | −58% |
|---|
| FY22 | −84.6% | −80.4% |
|---|
| FY21 | −54.7% | −71.9% |
|---|
| FY20 | −55.2% | −62.2% |
|---|
| FY19 | −51.7% | −46.3% |
|---|
| FY18 | −34.9% | −49.6% |
|---|
| FY17 | −11.1% | −45.9% |
|---|
| FY16 | 5.4% | −36% |
|---|
| FY15 | - | −38.4% |
|---|
| FY14 | −8.4% | −35.5% |
|---|
| FY13 | - | −37.1% |
|---|